A detailed history of Ims Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ims Capital Management holds 14,740 shares of MRK stock, worth $1.47 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
14,740
Previous 12,540 17.54%
Holding current value
$1.47 Million
Previous $1.55 Million 7.8%
% of portfolio
0.76%
Previous 0.71%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 17, 2024

BUY
$111.15 - $128.97 $244,530 - $283,734
2,200 Added 17.54%
14,740 $1.67 Million
Q2 2024

Aug 21, 2024

SELL
$123.8 - $132.96 $42,834 - $46,004
-346 Reduced 2.69%
12,540 $1.55 Million
Q1 2024

Jun 12, 2024

SELL
$113.24 - $131.95 $13,362 - $15,570
-118 Reduced 0.91%
12,886 $1.7 Million
Q4 2023

Apr 01, 2024

SELL
$100.18 - $109.02 $12,322 - $13,409
-123 Reduced 0.94%
13,004 $1.42 Million
Q3 2023

Oct 10, 2023

BUY
$102.95 - $114.33 $205 - $228
2 Added 0.02%
13,127 $1.35 Million
Q2 2023

Sep 13, 2023

SELL
$108.61 - $118.38 $20,961 - $22,847
-193 Reduced 1.45%
13,125 $1.51 Million
Q1 2023

Sep 13, 2023

SELL
$102.94 - $114.86 $236,556 - $263,948
-2,298 Reduced 14.72%
13,318 $1.42 Million
Q4 2022

Feb 22, 2023

BUY
$87.44 - $112.11 $201,286 - $258,077
2,302 Added 17.29%
15,616 $1.73 Million
Q3 2022

Nov 17, 2022

SELL
$84.53 - $94.96 $239,473 - $269,021
-2,833 Reduced 17.55%
13,314 $1.15 Million
Q2 2022

Jul 13, 2022

BUY
$83.49 - $94.64 $225,756 - $255,906
2,704 Added 20.11%
16,147 $1.47 Million
Q1 2022

Apr 08, 2022

BUY
$73.51 - $82.4 $25,875 - $29,004
352 Added 2.69%
13,443 $1.1 Million
Q4 2021

Jan 05, 2022

BUY
$72.28 - $90.54 $70,689 - $88,548
978 Added 8.07%
13,091 $1 Million
Q3 2021

Oct 07, 2021

BUY
$71.68 - $78.83 $52,828 - $58,097
737 Added 6.48%
12,113 $910,000
Q2 2021

Jul 07, 2021

SELL
$70.31 - $77.77 $27,983 - $30,952
-398 Reduced 3.38%
11,376 $885,000
Q1 2021

Apr 22, 2021

BUY
$68.86 - $81.11 $9,158 - $10,787
133 Added 1.14%
11,774 $908,000
Q4 2020

Jan 12, 2021

SELL
$71.77 - $79.65 $17,798 - $19,753
-248 Reduced 2.09%
11,641 $952,000
Q3 2020

Nov 05, 2020

SELL
$73.18 - $82.95 $146,213 - $165,734
-1,998 Reduced 14.39%
11,889 $986,000
Q2 2020

Jul 15, 2020

BUY
$70.42 - $80.13 $111,052 - $126,365
1,577 Added 12.81%
13,887 $1.07 Million
Q1 2020

Apr 03, 2020

BUY
$63.36 - $87.82 $30,539 - $42,329
482 Added 4.08%
12,310 $947,000
Q4 2019

Jan 15, 2020

BUY
$77.58 - $87.54 $155 - $175
2 Added 0.02%
11,828 $1.08 Million
Q3 2019

Oct 09, 2019

BUY
$76.08 - $82.93 $22,976 - $25,044
302 Added 2.62%
11,826 $996,000
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $40,577 - $47,403
581 Added 5.31%
11,524 $966,000
Q1 2019

May 21, 2019

SELL
$69.58 - $79.36 $226,204 - $257,999
-3,251 Reduced 22.9%
10,943 $910,000
Q4 2018

Feb 07, 2019

BUY
$65.24 - $75.71 $197,611 - $229,325
3,029 Added 27.13%
14,194 $1.09 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $4,961 - $5,834
86 Added 0.78%
11,165 $0
Q2 2018

Jul 26, 2018

BUY
$50.83 - $59.72 $59,979 - $70,469
1,180 Added 11.92%
11,079 $672,000
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $42,276 - $50,483
-819 Reduced 7.64%
9,899 $557,000
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $628,825 - $676,627
10,718
10,718 $686,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ims Capital Management Portfolio

Follow Ims Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ims Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Ims Capital Management with notifications on news.